Showing results (951-960 of 1,291) with videos related to

Sort By:
Pageof 130
Scientific Reports|September 28, 2024
Altered functional brain connectivity, efficiency, and information flow associated with brain fog after mild to moderate COVID-19 infectionShelli R Kesler, Oscar Y Franco-Rocha, Alexa De La Torre Schutz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 14, 2009
Gemini: a noninferiority study of saquinavir/ritonavir versus lopinavir/ritonavir as initial HIV-1 therapy in adultsSharon Walmsley, Anchalee Avihingsanon, Jihad Slim, et al.
JAMA|April 22, 1992
The effect of digital rectal examination on prostate-specific antigen levelsE D Crawford, M J Schutz, S Clejan, et al.
The Lancet. Microbe|June 1, 2022
Xpert Ultra testing of blood in severe HIV-associated tuberculosis to detect and measure Mycobacterium tuberculosis blood stream infection: a diagnostic and disease biomarker cohort studyLinda Boloko, Charlotte Schutz, Nomfundo Sibiya, et al.
Critical Care Explorations|January 13, 2025
Representation of Hispanic Patients in Clinical Trials for Respiratory Failure: A Systematic ReviewEmily A Harlan, Kaitlin Malley, Grecia Quiroga, et al.
Environmental Science & Technology|November 2, 2023
Prevalence and Source Tracing of PFAS in Shallow Groundwater Used for Drinking Water in Wisconsin, USAMatthew Silver, William Phelps, Kevin Masarik, et al.
Medwave|December 29, 2021
Predictors of recurrence of venous thromboembolic disease after discontinuing of anticoagulation: a prospective cohort studyMaría Lourdes Posadas-Martínez, Felipe Torres Gómez, Daniela Mezzarobba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2010
Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimensJoaquim Bellmunt, Toni K Choueiri, Ronan Fougeray, et al.
Oncotarget|November 16, 2017
Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trialsRaphael B Moreira, Marcio Debiasi, Edoardo Francini, et al.
British Journal of Clinical Pharmacology|January 9, 2020
Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus-associated tuberculosisCharlotte Schutz, Maxwell Chirehwa, David Barr, et al.
Pageof 130